KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Biogen (BIIB) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $779.9 million.

  • Biogen's Accumulated Depreciation & Amortization rose 1584.97% to $779.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $779.9 million, marking a year-over-year increase of 1584.97%. This contributed to the annual value of $779.9 million for FY2025, which is 1584.97% up from last year.
  • Latest data reveals that Biogen reported Accumulated Depreciation & Amortization of $779.9 million as of Q4 2025, which was up 1584.97% from $579.7 million recorded in Q3 2025.
  • Biogen's 5-year Accumulated Depreciation & Amortization high stood at $779.9 million for Q4 2025, and its period low was $102.6 million during Q1 2021.
  • Its 5-year average for Accumulated Depreciation & Amortization is $361.5 million, with a median of $353.8 million in 2021.
  • Per our database at Business Quant, Biogen's Accumulated Depreciation & Amortization skyrocketed by 3947.37% in 2022 and then crashed by 2152.34% in 2023.
  • Over the past 5 years, Biogen's Accumulated Depreciation & Amortization (Quarter) stood at $487.7 million in 2021, then grew by 6.29% to $518.4 million in 2022, then dropped by 4.55% to $494.8 million in 2023, then soared by 36.05% to $673.2 million in 2024, then rose by 15.85% to $779.9 million in 2025.
  • Its Accumulated Depreciation & Amortization was $779.9 million in Q4 2025, compared to $579.7 million in Q3 2025 and $377.5 million in Q2 2025.